Literature DB >> 8329196

Serum immunoglobulin (G, A and M) classes and IgG subclasses in sickle cell anaemia.

C Hedo1, Y Aken'Ova, I Okpala, L Salimonu.   

Abstract

Serum concentrations of immunoglobulins G, A, M and IgG subclasses were determined by single radial immunodiffusion assay in a population of sickle cell anaemia patients resident in the tropics. Fifty apparently healthy subjects of haemoglobin genotype AA, of comparable age, sex and socioeconomic status (SES), and in the same environment as the patients, were included as controls. Three indices of morbidity in SCA, namely frequency of crisis, degree of anaemia and the number of organ complications, were used to derive a severity score for each patient; and thus categorize the subjects into severity groups. Immunoglobulin levels were then correlated with the indices of morbidity as well as the derived severity score. IgG, IgA, IgM, IgG1 and IgG3 levels were significantly raised in the SCA subjects when they were compared as a group with the controls. When separated into disease severity groups, the mildly affected patients were found to have virtually normal levels of immunoglobulins. Total IgG concentration and level of the IgG3 subclass showed significant positive correlation with frequency of crisis and derived severity score. Markedly raised levels of IgG and IgG3 may be predictive of severity in sickle cell anaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329196     DOI: 10.1111/j.1699-0463.1993.tb00121.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Role of immunoglobulin G subclasses in Q fever.

Authors:  M T Camacho; I Outschoorn; A Tellez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

2.  Serum Immunoglobulin Levels in Children with Sickle Cell Disease: A Large Prospective Study.

Authors:  Sophia Cherif-Alami; Isabelle Hau; Cécile Arnaud; Annie Kamdem; Basil Coulon; Elodie Idoux; Stéphane Bechet; Rita Creidy; Françoise Bernaudin; Ralph Epaud; Corinne Pondarré
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.